Intra-Cellular Therapies (ITCI) PT Raised to $96 at Mizuho
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Intra-Cellular Therapies (ITCI) PT Raised to $105 at Jefferies
April 18, 2024 8:04 AM EDTJefferies analyst Andrew Tsai raised the price target on Intra-Cellular Therapies (NASDAQ: ITCI) to $105.00 (from $100.00) while maintaining a Buy rating.... More



